← Snapshot 21

Orange Book snapshot 21: Products

Products page 71 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
3502A074014003KETOPROFENCAPSULE;ORALCAPSULEORALKETOPROFENHERITAGE PHARMS INC75MGAB["AB"]1993-01-29Jan 29, 1993NoNoNoRXHERITAGE PHARMACEUTICALS INCb4d54a2274a977a46759d94c071e429b8f3c46ad7db689c286ca4d1439d28267
3503A074035002KETOPROFENCAPSULE;ORALCAPSULEORALKETOPROFENMYLAN50MG[]1996-12-31Dec 31, 1996NoNoNoDISCNMYLAN PHARMACEUTICALS INCfa9747b19ac6bdd9a65e9bb4f757f9d51f2e0a5e2a47d1d0502b9276cd191fe6
3504A074035003KETOPROFENCAPSULE;ORALCAPSULEORALKETOPROFENMYLAN75MG[]1996-12-31Dec 31, 1996NoNoNoDISCNMYLAN PHARMACEUTICALS INCc6b3522ff2d1a38893fed23ccdca336ce033be512d820c0b8e8b5a7c610565a7
3505A074024001KETOPROFENCAPSULE;ORALCAPSULEORALKETOPROFENRISING50MG[]1995-12-29Dec 29, 1995NoNoNoDISCNRISING PHARMA HOLDINGS INC4abb50a14ff0bfc11a9751e9d5cc076f3a7031a091524b8986137bf5a508ea0e
3506A074024002KETOPROFENCAPSULE;ORALCAPSULEORALKETOPROFENRISING75MG[]1995-12-29Dec 29, 1995NoNoNoDISCNRISING PHARMA HOLDINGS INCdcfd563e5edcb903cb99f8a98338d209a1c53f4bc710bbe59011debd3a1fc6ae
3507A073515001KETOPROFENCAPSULE;ORALCAPSULEORALKETOPROFENTEVA25MG[]1992-12-22Dec 22, 1992NoNoNoDISCNTEVA PHARMACEUTICALS USA INCe0831a11f57aa05f298e013ce2d6c3db797b24e05846a662b53193ed80c81630
3508A073516001KETOPROFENCAPSULE;ORALCAPSULEORALKETOPROFENTEVA50MGAB["AB"]1992-12-22Dec 22, 1992NoNoNoRXTEVA PHARMACEUTICALS USA INC4aa0d39c1b1bbeb3f9e107479e039ca4b9a276828deb649d76a6dcf8a621dcd1
3509A073517001KETOPROFENCAPSULE;ORALCAPSULEORALKETOPROFENTEVA75MGAB["AB"]1992-12-22Dec 22, 1992NoNoYesRXTEVA PHARMACEUTICALS USA INC7e66879a90783312402cd7b24818ecc61905b38a82c0f46bdab5971aad83ac2c
3510N213756001SELUMETINIB SULFATECAPSULE;ORALCAPSULEORALKOSELUGOASTRAZENECAEQ 10MG BASE[]2020-04-10Apr 10, 2020NoYesNoRXASTRAZENECA PHARMACEUTICALS LP392a389d28d7dcd431799fa5bf0d5e7fc5d0c822a57384240258ec0466d2f0ac
3511N213756002SELUMETINIB SULFATECAPSULE;ORALCAPSULEORALKOSELUGOASTRAZENECAEQ 25MG BASE[]2020-04-10Apr 10, 2020NoYesYesRXASTRAZENECA PHARMACEUTICALS LP6440e21a2773327a47a5fb67c86e4d531c9215a07243837a4de4d6b4ab6e9a18
3512N019500002CLOFAZIMINECAPSULE;ORALCAPSULEORALLAMPRENENOVARTIS50MG[]1986-12-15Dec 15, 1986NoYesNoDISCNNOVARTIS PHARMACEUTICALS CORP7d378b12f87033d36e40a048dd5aee01320e5f60b501fe8ca8e3819d9ac1d3b9
3513N019500001CLOFAZIMINECAPSULE;ORALCAPSULEORALLAMPRENENOVARTIS100MG[]1986-12-15Dec 15, 1986NoNoNoDISCNNOVARTIS PHARMACEUTICALS CORP2ae4731194da5b49ce3ae7a148d961e6f17326dbb9cc63dc25da8d38615dc261
3514A086996002ASPIRIN; BUTALBITAL; CAFFEINECAPSULE;ORALCAPSULEORALLANORINALLANNETT325MG;50MG;40MGAA["AA"]1985-10-11Oct 11, 1985NoNoNoRXLANNETT CO INCc9d08de789e8ba44b4469d4ab86566f3b2a7058703b6bf1531b1eb693a384fbf
3515N018118002DIGOXINCAPSULE;ORALCAPSULEORALLANOXICAPSGLAXOSMITHKLINE LLC0.05MG[]1982-07-26Jul 26, 1982NoNoNoDISCNGLAXOSMITHKLINE LLCb93d80ca451cbbeab44825fb6d2cecb07a3378d51ecef9f365ded6fff75b4873
3516N018118003DIGOXINCAPSULE;ORALCAPSULEORALLANOXICAPSGLAXOSMITHKLINE LLC0.1MG[]1982-07-26Jul 26, 1982NoNoNoDISCNGLAXOSMITHKLINE LLC03cdb2b0962d16b02016be98e1248d25806e144c8e4a5a2b1a9600a0b8315e88
3517N018118004DIGOXINCAPSULE;ORALCAPSULEORALLANOXICAPSGLAXOSMITHKLINE LLC0.15MG[]1984-09-24Sep 24, 1984NoNoNoDISCNGLAXOSMITHKLINE LLC3c0f46638b80eed2531056fcf858134fea5e840ee4b883f9c8c35f527941950d
3518N018118001DIGOXINCAPSULE;ORALCAPSULEORALLANOXICAPSGLAXOSMITHKLINE LLC0.2MG[]1982-07-26Jul 26, 1982NoNoNoDISCNGLAXOSMITHKLINE LLCebd39697c0a8d72ba67d2be522fc8d9f25d25e3487a84c30c33a2554000f0187
3519N016912002LEVODOPACAPSULE;ORALCAPSULEORALLARODOPAROCHE100MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNHOFFMANN LA ROCHE INC48fdad2aa8969c6d2f8770ce23c1f2f725db9af9c6b968564b0bbbe3bc42046a
3520N016912001LEVODOPACAPSULE;ORALCAPSULEORALLARODOPAROCHE250MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNHOFFMANN LA ROCHE INC2f4a02157abba47b3cc0ea393222bee828dc6b0d47d44646d6939aee9a69fc04
3521N016912006LEVODOPACAPSULE;ORALCAPSULEORALLARODOPAROCHE500MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNHOFFMANN LA ROCHE INCd3b6a802b28cdb0f47fda32f0cdc23d1cf003b84875e2e1d924a0741048bc29d
3522N206947001LENVATINIB MESYLATECAPSULE;ORALCAPSULEORALLENVIMAEISAI INCEQ 4MG BASE[]2015-02-13Feb 13, 2015NoYesNoRXEISAI INC5751a13918af89e19af02d7885502e1257628e6b79d3fa86a6934509faf2e18d
3523N206947002LENVATINIB MESYLATECAPSULE;ORALCAPSULEORALLENVIMAEISAI INCEQ 10MG BASE[]2015-02-13Feb 13, 2015NoYesYesRXEISAI INCa119a3552aae8c7928c8c33524a273345aceb1e41db0b52fb67990e4dae683a0
3524N020261001FLUVASTATIN SODIUMCAPSULE;ORALCAPSULEORALLESCOLNOVARTISEQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1993-12-31Dec 31, 1993NoYesNoDISCNNOVARTIS PHARMACEUTICALS CORPf65b8eca31ec014f5806d81206582a04f6bf0a6be8a560db30ddabc530e2e157
3525N020261002FLUVASTATIN SODIUMCAPSULE;ORALCAPSULEORALLESCOLNOVARTISEQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1993-12-31Dec 31, 1993NoYesNoDISCNNOVARTIS PHARMACEUTICALS CORPc2f4047623999c844b7f1aaf5d57e486e4f8fa5d64a53ed5b3a3ef01ce92f6b3
3526A211369001LEVOTHYROXINE SODIUMCAPSULE;ORALCAPSULEORALLEVOTHYROXINE SODIUMTEVA PHARMS USA INC0.075MGAB["AB"]2020-10-28Oct 28, 2020NoNoNoRXTEVA PHARMACEUTICALS USA INC85c1f4f3523574983590168321e3de34ea817ef4bd2c747b7a36c93b1a0c7ab7
3527A213256001LEVOTHYROXINE SODIUMCAPSULE;ORALCAPSULEORALLEVOTHYROXINE SODIUMTEVA PHARMS USA INC0.088MGAB["AB"]2021-01-06Jan 6, 2021NoNoNoRXTEVA PHARMACEUTICALS USA INC229df4d9b47b0fb553198f838b48d723a4213bad6b46ca5eb7a06e3848599e03
3528A213256002LEVOTHYROXINE SODIUMCAPSULE;ORALCAPSULEORALLEVOTHYROXINE SODIUMTEVA PHARMS USA INC0.1MGAB["AB"]2021-01-06Jan 6, 2021NoNoNoRXTEVA PHARMACEUTICALS USA INCa0abfcc9719f55f23b8e2f7bba3def29a1489fb353dd828271283d7a1510f05b
3529A213256003LEVOTHYROXINE SODIUMCAPSULE;ORALCAPSULEORALLEVOTHYROXINE SODIUMTEVA PHARMS USA INC0.125MGAB["AB"]2021-01-06Jan 6, 2021NoNoNoRXTEVA PHARMACEUTICALS USA INC98c92b23b939cd0a079d396321a846a0bd104825a8b6c702a7f4d80d72b73c5d
3530A211369002LEVOTHYROXINE SODIUMCAPSULE;ORALCAPSULEORALLEVOTHYROXINE SODIUMTEVA PHARMS USA INC0.15MGAB["AB"]2020-10-28Oct 28, 2020NoNoNoRXTEVA PHARMACEUTICALS USA INC0f8500fdb845e1ab563f702e0e335409987203e72d9e164e3044f7668accaa02
3531N012750001CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDECAPSULE;ORALCAPSULEORALLIBRAXBAUSCH5MG;2.5MGAB["AB"]Approved Prior to Jan 1, 1982YesYesYesRXBAUSCH HEALTH US LLC004ebef5e5153c797017d4ed051aa46b3f35c0dc227de5b07c663473230d47ff
3532A085461001CHLORDIAZEPOXIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLIBRIUMVALEANT PHARM INTL5MGAB["AB"]Approved Prior to Jan 1, 1982YesNoNoRXVALEANT PHARMACEUTICALS INTERNATIONAL63187492cb09ee30e0dd2110df0823cb223ea4c2822c62b1b75efb9c937a85bd
3533N012249002CHLORDIAZEPOXIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLIBRIUMVALEANT PHARM INTL5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNVALEANT PHARMACEUTICALS INTERNATIONAL954e9b7b4c495a9233ee3189560c046a1609cb6a2d54236e9f9fe83d8b5cb4ff
3534A085472001CHLORDIAZEPOXIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLIBRIUMVALEANT PHARM INTL10MGAB["AB"]Approved Prior to Jan 1, 1982YesNoNoRXVALEANT PHARMACEUTICALS INTERNATIONALa97aecde2ce46903079da79e99f0ff92d7777df0832788227b702d6886266e18
3535N012249001CHLORDIAZEPOXIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLIBRIUMVALEANT PHARM INTL10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNVALEANT PHARMACEUTICALS INTERNATIONALe8bad935e1458de03de432e3ca320ab2f3f92fb0aa386157bf41778621aa7fb0
3536A085475001CHLORDIAZEPOXIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLIBRIUMVALEANT PHARM INTL25MGAB["AB"]Approved Prior to Jan 1, 1982YesNoYesRXVALEANT PHARMACEUTICALS INTERNATIONAL3e96d51773aff1d00db993a20fd2e2dddca220ae7be712b16f97039984cfde81
3537N012249003CHLORDIAZEPOXIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLIBRIUMVALEANT PHARM INTL25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNVALEANT PHARMACEUTICALS INTERNATIONAL9fb44c76c093cae4509c9fdc9af890c75db14d598a32e44a8058128a8a92c1a2
3538A209564001LINACLOTIDECAPSULE;ORALCAPSULEORALLINACLOTIDEMYLAN145MCG[]2021-02-09Feb 9, 2021NoNoNoDISCNMYLAN PHARMACEUTICALS INC5a316469564a859a84d27deeb961f8b1e1adcb0a1aac61ccb063608f050030dd
3539A209564002LINACLOTIDECAPSULE;ORALCAPSULEORALLINACLOTIDEMYLAN290MCG[]2021-02-09Feb 9, 2021NoNoNoDISCNMYLAN PHARMACEUTICALS INC44bed89908ebe994d36f6ba9f6788a369388d76909d12ff025bd0cdb39a55d17
3540N050316001LINCOMYCIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALLINCOCINPHARMACIA AND UPJOHNEQ 250MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNPHARMACIA AND UPJOHN CO6fe8bdc3813b7b64054784201f77a130827cc4a1abeb866467ba50c60e3585c2
3541N050316002LINCOMYCIN HYDROCHLORIDECAPSULE;ORALCAPSULEORALLINCOCINPHARMACIA AND UPJOHNEQ 500MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNPHARMACIA AND UPJOHN CO6012d89fc3d24ec4c85f8cd7021f446d0d46cdcc9e78a36004e0c67a3490349d
3542N202811003LINACLOTIDECAPSULE;ORALCAPSULEORALLINZESSALLERGAN72MCG[]2017-01-25Jan 25, 2017NoYesYesRXALLERGAN SALES LLC39226ac9f3bd4b5d2733948c8776c4bbe5d9d556a157ded7fb475e0f5befb82f
3543N202811001LINACLOTIDECAPSULE;ORALCAPSULEORALLINZESSALLERGAN145MCG[]2012-08-30Aug 30, 2012NoYesYesRXALLERGAN SALES LLCeb9f555906a60b8a0bb317ee9572523ce2214c56118da6eb82eb7466e83b6e46
3544N202811002LINACLOTIDECAPSULE;ORALCAPSULEORALLINZESSALLERGAN290MCG[]2012-08-30Aug 30, 2012NoYesNoRXALLERGAN SALES LLCc30688c60ace5d747833c5af2c30a7b9925ee612568ad401a85abe28b29306a6
3545N019304001FENOFIBRATECAPSULE;ORALCAPSULEORALLIPIDILABBVIE100MG[]1993-12-31Dec 31, 1993NoNoNoDISCNABBVIE INC0437979dbbaa4ef4ed5d42f9eb15f3032e1a6475836db7f42689233fdca5825c
3546N021612001FENOFIBRATECAPSULE;ORALCAPSULEORALLIPOFENCIPHER PHARMS INC50MG[]2006-01-11Jan 11, 2006NoYesNoRXCIPHER PHARMACEUTICALS INCaa38ee47daa182c52ad8968422394dbe348113f04fa9dfefab87c875f4f6f5cc
3547N021612002FENOFIBRATECAPSULE;ORALCAPSULEORALLIPOFENCIPHER PHARMS INC100MG[]2006-01-11Jan 11, 2006NoNoNoDISCNCIPHER PHARMACEUTICALS INCc7dfecd8480d019d140fe490494a6378aba757d7d19f574ba569b37865ffaeaf
3548N021612003FENOFIBRATECAPSULE;ORALCAPSULEORALLIPOFENCIPHER PHARMS INC150MG[]2006-01-11Jan 11, 2006NoYesYesRXCIPHER PHARMACEUTICALS INCf63761baffee31997a81ac28099fee08e5cedae1a62935c729bf2a53e5b37296
3549A076823001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEABLE150MG[]2004-06-29Jun 29, 2004NoNoNoDISCNABLE LABORATORIES INC4a1c841c0c2db93c3b04c97d772199f067cc666227aea2e0af82811d3e0ae485
3550A076121001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEABLE300MG[]2001-09-27Sep 27, 2001NoNoNoDISCNABLE LABORATORIES INC3e361ab553bd1e3f0cde2e17e35728c716268f36f25ace67e9642fdbc2092b20
3551A076823002LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEABLE300MG[]2004-06-29Jun 29, 2004NoNoNoDISCNABLE LABORATORIES INC0506964c9628d57018f46ad83e215f275a1446a26c88f475d1f8cb76e20f479e